Friday, February 7, 2014
During gene transcription ER functions not only to recruit an in tricate network
Macrophages constitutively expressing Ets2 are a product sys tem for differentiating between cell proliferation and survival. CSF one enables these cells to proliferate, although Cilengitide Integrin inhibitor Ets2 compen sates because of its absence simply by avoiding these cells from us dergoing apoptosis and not by letting expansion, as is the case with broblasts exogenously expressing CSF 1R. Thus, although Ets2 seems to are likely involved in CSF 1 transmission ent in both cell types, Ets2 isn't sufcient to fully simulate the activity of CSF 1 in macrophages. Our attempts to determine BAC1. 2F5 macrophages constitu tively expressing a dominant negative mutant form of Ets2 were defeated. The same retroviral supernatants were successfully applied to invade CSF 1 separate BAC1.
2F5 cells constitutively expressing v raf, While bad, these,results suggested to us that the expression of a dominant neg ative type of Ets2 Endosymbiotic theory is incompatible with cell SJN 2511 survival in this system. There-Fore, expression of the dominant negative type of Ets2 inhibits cell growth in broblasts and might be incompatible with cell growth or survival in BAC1. 2F5 macrophages, thus explaining the impossibility of obtaining BAC1. 2F5 cells constitutively expressing a dominant negative type of Ets2. While CSF 1 binds to its receptor, a number of signaling events occurs, including the service of a cytoplasmic kinase, Raf, BAC1. 2F5 tissue, Employing this program it was shown that raf activates at-least two independent signaling pathways, It's probable that one of these includes Ets2 and another includes Myc and that the activation of Ets2 in one walkway would be insufcient to cause proliferation minus the concurrent activation of Myc. We're currently investigating whether the activation of Myc with Ets2 will be sufcient to encourage these changes displayed by Raf expression.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment